Hernández PM, González SN

Language: Spanish
References: 21
Page: 545-549
PDF size: 178.99 Kb.

ABSTRACT

Dengue (DEN) is a viral and febrile systemic and dynamic infectious disease. Mainly transmitted by the mosquito Aedes. It is estimated that annually occur between 50-100 million people infected in endemic areas. In Mexico, the disease is found in 28 of the 32 states of Mexican Republic. There are presented 3 clinical phases: febrile, critical and recovery. Confirmatory testing is performed by RT-PCR. To date, there is not a specific DEN treatment. Vaccination is completing phase III studies.

REFERENCES

1. Global strategy for dengue prevention and control 2012- 2020, disponible en: http://apps.who.int/iris/bitstre am/10665/75303/1/9789241504034_eng.pdf?ua=1

2. Organización Panamericana de la Salud. Organización Mundial de la Salud. Dengue: Guías para el diagnóstico, tratamiento, prevención y control. La Paz, Bolivia, OPS/OMS, 2010.

3. San Martín JL, Brathwaite O, Zambrano Betzana, Solórzano JO, Bouckenooghe A, Dayan G, Guzmán MG. The epidemiology of Dengue in the Americas over the last three decades: A worrisome reality. 2010, Am J Trop Med Hyg; 82:128-35.

4. Simmons CP, Farrar JJ, Vinh Chau N, Wills B. Dengue. 2012, N Engl J Med; 366:1423-32.

5. Lindenbach B, Thiel HJ, Rice CM. Flaviviridae: The viruses and their replication, en: Fields Virology, 5th edition. DM Knipe and Howley PM, EDs. Lippincott-Raven Publishers, Philadelphia 2007.

6. Gubler, DJ. Dengue and Dengue Hemorrhagic Fever. ClinMicrobiol Rev. 1998;11:480-496.

7. Tapia-Conyer R, Méndez-Galván J, Burciaga-Zuñiga P. Community participation in the prevention and control of dengue: the patio limpio strategy in México. 2012, Paerdiatrics and International Child Health, 32 (S1): 10-13.

8. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature, 2013; 496:504-507.

9. Secretaría de Salud, Mexico. Disponible en: http://www. epidemiologia.salud.gob.mx/dgae/infoepid/inicio_anuarios.html anuarios 2013, Consulta: 20/Ago/2014.

10. Secretaría de Salud México. http://www.epidemiologia.salud. gob.mx/dgae/panodengue/intd_dengue.html Consulta 20/ Ago/2014.

11. Dirección General de Información en Salud (DGIS). Base de datos de egresos hospitalarios por morbilidad en Instituciones Públicas, 2004-2007. [en línea]: Sistema Nacional de Información en Salud (SINAIS). [México]: Secretaría de Salud. [Consulta: 25mayo 2014].

12. Shepard D, Betancourt CM,

13. Shepard D, Coudeville L, Holasa Y, Zambrano B, et al. Economic impact of dengue illnes in the Americas. Am J Trop Med Hyg. 2011; 84:200-7.

14. Rothman A, Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nature, 2011;11:532-43.

15. Martina BE, Koraka P, Osterhaus A. Dengue virus pathogenesis: an integrated view. 2009. Clin Microbiol Rev, 22:564-80

16. Olkowski S, Forshey BM, Morrison CR, Vilcarromero S, Halsey ES, Kochel TJ, Scott TW, Stoddard ST. Reduced Risk of Disease during Postsecondary dengue virus infections. JID, 2013;208:1026-1033.

17. Ramos C, García H, Villaseca J. Fiebre hemorrágica y síndrome de choque por dengue. Salud Pública Mex, 1993;35:39-55.

18. Malavigne GN, Fernando S, Fernando DJ, Seneviratne SL. Dengue viral infections. Postgrad Med J. 2004;80:588-601.

19. Salgado DM, Rodríguez JA, Lozano LP, Zabaleta TE. Dengue perinatal. Biomédica, 2013;33,sup1:14-21.

20. Karunakaran A, Mohammed W, Sheen SF, et al. Risk factors of mortality among dengue patients admitted to a tertiary care setting in Kerala, India. 2014, J Infect and Pub Health; 7:114-20.

21. Capeding MR, Tran N, Rezeki A, Hadinegoro S, et al. Clinical efficacy and safety of a novel tetravalent denguevaccine in healthy children in Asia: a phase 3, randomised,observer-masked, placebo-controlled trial. Published OnlineJuly 11, 2014http:// dx.doi.org/10.1016/S0140-6736(14)61060-6.